JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Winder, C. V.
Right arrow Articles by Short, F. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Winder, C. V.
Right arrow Articles by Short, F. W.
Journal of Pharmacology And Experimental Therapeutics, Vol. 138, Issue 3, 405-413, 1962
Copyright © 1962 by American Society for Pharmacology and Experimental Therapeutics


ANTI-INFLAMMATORY, ANTIPYRETIC AND ANTINOCICEPTIVE PROPERTIES OF N-(2,3-XYLYL)ANTHRANILIC ACID (MEFENAMIC ACID)

C. V. Winder 1, J. Wax 1, L. Scotti 1, R. A. Scherrer 1, E. M. Jones 1, and F. W. Short 1

1 Departments of Pharmacology and Chemistry, Research Division, Parke, Davis & Company, Ann Arbor, Michigan

N-(2,3-xylyl)anthranilic acid (CI-473; mefenamic acid) is an anti-inflammatory agent with an acute potency 0.51 (0.37 to 0.71)95% that of phenylbutazone as determined orally in the UV-erythema assay in guinea pigs. In the subcutaneous cotton-pellet test in rats it exhibits a significantly though shallowly dose-graded anti-granulation effect, paralleling that of phenylbutazone at a subacute (oral) potency of 0.6 (0.1 to 2.1)95%, without adrenal dependence or significant corticoid hormonal effects. It antagonizes yeast pyresis in rats with about the same acute oral potency as phenylbutazone. In quantitative tail-pinching experiments with rats, CI-473 exhibits a grade of antinociceptive effect approximating that of aminopyrine, with a mg potency 1.4 (0.95 to 2.0)95% times that of aminopyrine 30 minutes after intraperitoneal administration. Its dose-effect relationship is altered qualitatively in guinea pigs on intragastric administration in solution (as a salt) in the presence of food. The sodium salt is a tissue irritant in rodents, in concentrations suitable for ordinary parenteral administration, though supratherapeutic dosage rates are systemically tolerated by the intravenous route in rats. Twenty rats, half of them adrenalectomized, tolerated the finely suspended free acid by gavage at the rate of 100 mg/kg day for 7 days without incident.

Submitted on August 4, 1962




This article has been cited by other articles:


Home page
ScienceHome page
H. Levitan and J. L. Barker
Salicylate: A Structure-Activity Study of its Effects on Membrane Permeability
Science, June 30, 1972; 176(4042): 1423 - 1425.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1962 by the American Society for Pharmacology and Experimental Therapeutics.